Global Pancreatic Cancer Therapeutics and Diagnostics Market 2022-2028

Global Pancreatic Cancer Therapeutics and Diagnostics Market 2022-2028

According to market research study published by Gen Consulting Company, the market size of the global pancreatic cancer therapeutics and diagnostics sector is expected to rise by USD 1.9 billion with a CAGR of 7% by the end of 2028.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global pancreatic cancer therapeutics and diagnostics market. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the pancreatic cancer therapeutics and diagnostics industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, and region. The global market for pancreatic cancer therapeutics and diagnostics can be segmented by type: treatment, diagnostics. Among these, the treatment segment was accounted for the highest revenue generator in 2021. Pancreatic cancer therapeutics and diagnostics market is further segmented by region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. Europe is estimated to account for the largest share of the global pancreatic cancer therapeutics and diagnostics market.

The treatment market is further segmented into targeted therapies, chemotherapy, surgery, others. The chemotherapy segment captured the largest share of the market in 2021 and is expected to maintain its dominance during the forecast period. Furthermore, the diagnostics market has been categorized into imaging, biopsy, endoscopic ultrasound, others. According to the research, the imaging segment had the largest share in the global pancreatic cancer therapeutics and diagnostics market.

Market Segmentation

By type: treatment, diagnostics

By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report has also analysed the competitive landscape of the global pancreatic cancer therapeutics and diagnostics market with some of the key players being Amgen Inc, AstraZeneca plc, Boston Scientific Corporation, Bristol Myers Squibb Company, Canon Inc., Fujifilm Holdings Corporation, Merck KGaA, Novartis AG, Pfizer Inc., Roche Holding AG, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global pancreatic cancer therapeutics and diagnostics market.
• To classify and forecast the global pancreatic cancer therapeutics and diagnostics market based on type, region.
• To identify drivers and challenges for the global pancreatic cancer therapeutics and diagnostics market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global pancreatic cancer therapeutics and diagnostics market.
• To identify and analyze the profile of leading players operating in the global pancreatic cancer therapeutics and diagnostics market.

• Gain a reliable outlook of the global pancreatic cancer therapeutics and diagnostics market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.